Literature DB >> 9480862

Catalytic properties of class A beta-lactamases: efficiency and diversity.

A Matagne1, J Lamotte-Brasseur, J M Frère.   

Abstract

beta-Lactamases are the main cause of bacterial resistance to penicillins, cephalosporins and related beta-lactam compounds. These enzymes inactivate the antibiotics by hydrolysing the amide bond of the beta-lactam ring. Class A beta-lactamases are the most widespread enzymes and are responsible for numerous failures in the treatment of infectious diseases. The introduction of new beta-lactam compounds, which are meant to be 'beta-lactamase-stable' or beta-lactamase inhibitors, is thus continuously challenged either by point mutations in the ubiquitous TEM and SHV plasmid-borne beta-lactamase genes or by the acquisition of new genes coding for beta-lactamases with different catalytic properties. On the basis of the X-ray crystallography structures of several class A beta-lactamases, including that of the clinically relevant TEM-1 enzyme, it has become possible to analyse how particular structural changes in the enzyme structures might modify their catalytic properties. However, despite the many available kinetic, structural and mutagenesis data, the factors explaining the diversity of the specificity profiles of class A beta-lactamases and their amazing catalytic efficiency have not been thoroughly elucidated. The detailed understanding of these phenomena constitutes the cornerstone for the design of future generations of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9480862      PMCID: PMC1219177          DOI: 10.1042/bj3300581

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  185 in total

Review 1.  Cell division and peptidoglycan assembly in Escherichia coli.

Authors:  N Nanninga
Journal:  Mol Microbiol       Date:  1991-04       Impact factor: 3.501

2.  A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.

Authors:  S Mariotte-Boyer; M H Nicolas-Chanoine; R Labia
Journal:  FEMS Microbiol Lett       Date:  1996-09-15       Impact factor: 2.742

3.  X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme.

Authors:  S Pares; N Mouz; Y Pétillot; R Hakenbeck; O Dideberg
Journal:  Nat Struct Biol       Date:  1996-03

4.  Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins.

Authors:  X Raquet; M Vanhove; J Lamotte-Brasseur; S Goussard; P Courvalin; J M Frère
Journal:  Proteins       Date:  1995-09

5.  Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.

Authors:  T Palzkill; Q Q Le; K V Venkatachalam; M LaRocco; H Ocera
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

6.  Complementary roles of mutations at positions 69 and 242 in a class A beta-lactamase.

Authors:  R A Bonomo; C G Dawes; J R Knox; D M Shlaes
Journal:  Biochim Biophys Acta       Date:  1995-02-22

7.  Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/intermediate of beta-lactam hydrolysis.

Authors:  C C Chen; J Rahil; R F Pratt; O Herzberg
Journal:  J Mol Biol       Date:  1993-11-05       Impact factor: 5.469

8.  Site-directed mutagenesis at the active site of Escherichia coli TEM-1 beta-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis.

Authors:  M Delaire; R Labia; J P Samama; J M Masson
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

9.  Active-site residues of the transpeptidase domain of penicillin-binding protein 2 from Escherichia coli: similarity in catalytic mechanism to class A beta-lactamases.

Authors:  H Adachi; M Ishiguro; S Imajoh; T Ohta; H Matsuzawa
Journal:  Biochemistry       Date:  1992-01-21       Impact factor: 3.162

10.  Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.

Authors:  G Vedel; A Belaaouaj; L Gilly; R Labia; A Philippon; P Névot; G Paul
Journal:  J Antimicrob Chemother       Date:  1992-10       Impact factor: 5.790

View more
  110 in total

1.  Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.

Authors:  L Poirel; I Le Thomas; T Naas; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  The Red Menace: Emerging Issues in Antimicrobial Resistance in Gram-Negative Bacilli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens.

Authors:  J W Decousser; L Poirel; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

4.  Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis.

Authors:  S Bellais; L Poirel; N Fortineau; J W Decousser; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

5.  Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase.

Authors:  Miriam Barlow; Barry G Hall
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

6.  Contribution of natural amino acid substitutions in SHV extended-spectrum beta-lactamases to resistance against various beta-lactams.

Authors:  C C Randegger; A Keller; M Irla; A Wada; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

7.  IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.

Authors:  P Giakkoupi; L S Tzouvelekis; A Tsakris; V Loukova; D Sofianou; E Tzelepi
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  Identification of a chromosome-borne expanded-spectrum class a beta-lactamase from Erwinia persicina.

Authors:  Sophie Vimont; Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

9.  Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans.

Authors:  Anne-Sophie Morin; Laurent Poirel; Francine Mory; Roger Labia; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.

Authors:  Pierre-Yves De Wals; Nicolas Doucet; Joelle N Pelletier
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.